| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |